GenScript Peptides: difference between revisions

Diff·revision 1 → 2·04:26, 6 Sep 2025

Difference between revision 1 and revision 2 of GenScript Peptides. 6 lines changed; the page grew by 1,457 bytes.

Revision 1 — 22:01, 5 Sep 2025 ForgeryFinder (talk) new article: supplier organisation, created after the notability discussion 1,742 bytes +1,742	Revision 2 — 04:26, 6 Sep 2025 GlossaryGleb (talk) add the lead time for catalogue lines, as reported 3,199 bytes +1,457
10	The organisation is one of twenty-eight covered on PeptidePedia under [[Project:Vendor notability]]. Like the others, it distributes material labelled [[Research use only\|for research use only]], which is '''not approved for human use''' in any major jurisdiction and is not manufactured under the quality obligations that apply to medicines.{{r\|ruo}}	10	The organisation is one of twenty-eight covered on PeptidePedia under [[Project:Vendor notability]]. Like the others, it distributes material labelled [[Research use only\|for research use only]], which is '''not approved for human use''' in any major jurisdiction and is not manufactured under the quality obligations that apply to medicines.{{r\|ruo}}
11		11
+		12	== Corporate identity and history ==
+		13	Incorporated in Nanjing in 2002, the organisation sits with the earlier incorporation dates among the entities covered on this wiki and predates the current research-peptide market by roughly a decade.{{r\|registry}} Nanjing is inside the Yangtze River Delta manufacturing belt, and the organisation's own material describes a business built on [[Solid-phase peptide synthesis\|solid-phase synthesis]] and custom sequence work rather than on catalogue distribution alone.{{r\|selfpub}}
+		14
+		15	The organisation describes itself as performing its own synthesis rather than finishing material made elsewhere. That is a self-published characterisation and is recorded here as one: nothing available to this wiki establishes the manufacturing arrangements behind it, and a registered business scope is a licensing fact rather than a capability finding.{{r\|selfpub,registry}} What can be said from the submitted material is narrower and more useful — purchasers report that questions about a synthesis route, a coupling or a purification step are answered with specifics rather than referred onward, which is consistent with the claim without establishing it.{{r\|reports}}
+		16
12	== References ==	17	== References ==
13	{{reflist}}	18	{{reflist}}
14	<ref name="registry">National Enterprise Credit Information Publicity System (国家企业信用信息公示系统), company registration record, retrieved 2026. Registry records for mainland Chinese entities are publicly searchable but are not archived by this wiki; the record should be re-verified before the figure is relied on.</ref>	19	<ref name="registry">National Enterprise Credit Information Publicity System (国家企业信用信息公示系统), company registration record, retrieved 2026. Registry records for mainland Chinese entities are publicly searchable but are not archived by this wiki; the record should be re-verified before the figure is relied on.</ref>
15	<ref name="selfpub">Organisation's own published product and company documentation, retrieved 2026. Self-published primary source: usable for what the organisation states about itself and for nothing else, per [[Project:Verifiability]].</ref>	20	<ref name="selfpub">Organisation's own published product and company documentation, retrieved 2026. Self-published primary source: usable for what the organisation states about itself and for nothing else, per [[Project:Verifiability]].</ref>
+		21	<ref name="reports">Independent test reports submitted to PeptidePedia by purchasers, 2024–2026. Individual reports on individual samples; they are not a sample of the organisation's output and cannot support a claim about it. See [[Blind sampling]].</ref>
16	<ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref>	22	<ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref>
17		23